BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Adaptimmune Ltd. 

57c Milton Park

Abingdon  Oxfordshire  OX14 4RX  United Kingdom
Phone: +44-(0)-1235-438-642 Fax: +44-(0)-1235-438-607


SEARCH JOBS










 Company News
Adaptimmune Ltd. Gets Ready To Double Headcount By The End Of 2014 6/4/2014 7:32:20 AM
Adaptimmune Ltd., GlaxoSmithKline (GSK) Strike $350 Million Cancer Immunotherapy Pact 6/2/2014 6:38:21 AM
Adaptimmune Ltd. Integrates BioLife Solutions, Inc. (BLFS.OB) CryoStor® Cell Freeze Media In Cancer Immunotherapy Clinical Trial 4/2/2014 10:55:17 AM
Adaptimmune Ltd. Announces Full-Time Appointment Of James Noble As Chief Executive Officer 3/26/2014 10:59:04 AM
Adaptimmune Ltd. Announces Award Of £2.1 Million From The Biomedical Catalyst Fund 3/25/2014 9:38:06 AM
Adaptimmune Ltd. Announces Interim Results From A Phase I/II Trial Of Engineered T Cells Targeting Cancer Testis Antigens In Multiple Myeloma 12/10/2013 9:49:56 AM
Adaptimmune Ltd. Appoints Dr. Jonathan Knowles As Chairman Of The Board 11/20/2013 3:19:59 PM
Adaptimmune Ltd. Announces Opening of Phase I/IIa Clinical Trial in Ovarian Cancer 7/25/2013 9:33:19 AM
Adaptimmune Ltd. Selects SCiAN Services' EDC(PRO) Solution to Support a Series of Clinical Trials Starting in 2013 2/12/2013 9:06:57 AM
NeoStem, Inc.'s Subsidiary, Progenitor Cell Therapy, Enters Into a Cell Therapy Manufacturing Services Agreement With Adaptimmune Ltd. 1/16/2013 9:18:02 AM
12